Publiziert in: Marktpuls, Unternehmen
Frei
Genentech : FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications Montag, 12. April 2021 - 19:58
Copyright (C) 2021 Genentech All rights reserved. |

